↓ Skip to main content
What is this page? Embed badge

Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study

Overview of attention for article published in Nature Cancer, April 2025
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

blogs
1 blog
twitter
11 X users
guideline
1 clinical guideline source
bluesky
2 Bluesky users

Readers on

mendeley
36 Mendeley
So far, Altmetric has seen 1 blog post.
This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.